Related Experiment Video
Updated: Aug 7, 2026
08:43
OLIgo Mass Profiling (OLIMP) of Extracellular Polysaccharides
Published on: June 20, 2010
Non-digestible oligosaccharides with prebiotic properties
Katrien Swennen1, Christophe M Courtin, Jan A Delcour
1Laboratory of Food Chemistry, Katholieke Universiteit Leuven, Kasteelpark Arenberg 20, B-3001, Leuven, Belgium. katrien.swennen@agr.kuleuven.ac.be
Critical Reviews in Food Science and Nutrition
|July 26, 2006
Summary
Non-digestible oligosaccharides are functional food ingredients gaining attention for their health benefits. This review covers their production, characterization, and positive effects on various health conditions and diseases.
Area of Science:
- Food Science
- Nutritional Science
- Microbiology
Background:
- Functional foods and ingredients are a major trend in the food industry.
- Probiotics (live microbial supplements) and prebiotics (non-digestible ingredients) are key areas of focus.
- Non-digestible oligosaccharides (NDOs) are a type of prebiotic receiving increasing attention.
Purpose of the Study:
- To review the production and characterization of NDOs.
- To explore the role of NDOs in promoting health and treating diseases.
- To examine NDO effects on specific health parameters.
Main Methods:
- Literature review on NDO production and characterization.
- Analysis of studies investigating NDOs' impact on health.
- Synthesis of evidence regarding NDOs' therapeutic potential.
Main Results:
- NDOs can be produced and characterized for various applications.
- Evidence suggests NDOs positively influence constipation, mineral absorption, and lipid metabolism.
- NDOs show potential in cancer prevention, managing hepatic encephalopathy, and modulating glycemia/insulinemia and immunity.
Conclusions:
- NDOs are versatile functional food ingredients with significant health-promoting properties.
- Further research into NDOs can lead to novel therapeutic strategies.
- NDOs represent a promising area for improving gastrointestinal and overall health.
Related Concept Videos
01:24Oligosaccharide Assembly
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
01:22Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Acarbose and miglitol are typically...
01:18Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
00:57Carbohydrate Digestion
Carbohydrate digestion and metabolism break down simple and complex carbohydrates from food into saccharides (i.e., sugars) for the body to use as energy. Carbohydrate digestion starts in the mouth during mastication, or chewing. The masticated carbohydrates remain intact in the stomach. Digestion resumes in the duodenum of the small intestine, where pancreatic alpha-amylase and brush border enzymes of the microvilli convert complex carbohydrates to monosaccharides. Finally, the monosaccharides...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...